CAR-T cell therapy for breast cancer: Current status and future perspective
A recent paper by Giuseppe Buono, Medical Doctor at IRCCS National Cancer Institute “Fondazione G. Pascale”, was mentioned by Elisa Agostinetto, Clinical Research Fellow at the Jules Bordet Institute, on X:
“Now out in Cancer Treatment Reviews a nice review on CAR-T cell therapy for breast cancer, a still experimental approach but with promising expectations for future development and implementation in clinical practice
“CAR-T cell therapy for breast cancer: Current status and future perspective”
Authors: Giuseppe Buono, Monica Capozzi, Roberta Caputo, Martina Pagliuca, Michelino De Laurentiis et al.
More posts featuring Elisa Agostinetto.
Dr. Elisa Agostinetto is a Clinical Research Fellow at the Jules Bordet Institute and a Medical Oncologist at the Brussels University Hospital. Specializing in breast cancer, her work focuses on advancing clinical oncology research and improving cancer treatment and patient care.
Actively involved in professional societies such as ESMO, ASCO, and BSMO, Dr. Agostinetto serves as a Young Investigator in the EORTC Breast Cancer Working Group and is a Committee Member of the Young Cancer Professionals within the European Cancer Organization.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023